Collectively, our findings suggested that NF-κB-mediated pyroptosis may play an important role in sevoflurane-induced cognitive deficits in the developing brain, and NF-κB inhibition might be a potential target for ameliorating neuroinflammation and GA-induced development-related neurocognitive dysfunction. The gene discussed is NFKB1; the disease is Cognitive impairment.